The most common head and neck cancer—oral squamous cell carcinoma—often starts off, as many other cancers do, quite innocently. Perhaps as a little white patch in the mouth or a small red bump on the gums. Easy to ignore, ...
Apr 26, 2022
0
19
Oral cancer is a common cancer that affects the head and neck region. Around 50% of oral cancer patients do not survive for more than five years, even after treatment, as many patients seek medical help only during the late ...
Apr 11, 2022
0
24
A research group led by Associate Professor Ryoji Yoshida and Professor Hideki Nakayama from the Department of Oral and Maxillofacial Surgery in Kumamoto University (Japan) has analyzed the extracellular vesicles (EVs) of ...
Dec 16, 2021
0
1
Microscopic fungus may have more to do with oral cancer and aging than first thought, according to new research from Case Western Reserve University.
Jul 28, 2021
0
4
A collaborative research led by immunologist Estefania Nova-Lamperti from the Universidad de Concepción (Chile), with a branch of researchers from MELISA Institute and other international academic centers, made progress ...
Jun 2, 2021
0
10
Up to half of patients with head and neck squamous cell carcinoma will experience tumor recurrence or new tumors—tumors that often spread and are difficult to treat.
May 26, 2021
0
11
An in vitro study conducted by a group of researchers at São Paulo State University (UNESP) in Araraquara, Brazil, shows how fungi and bacteria can activate genes associated with head and neck tumors, as the metabolism of ...
May 25, 2021
0
4
MUSC Hollings Cancer Center researchers are exploring the use of peptide carriers for the delivery of small RNA drugs as a novel treatment for cancer. The team's recent work, published online March 19 in the Molecular Therapy—Nucleic ...
May 24, 2021
0
5
Screening and the HPV vaccine have led to drops in cervical cancers over the last two decades in the U.S., a new study finds, but the gains are offset by a rise in other tumors caused by the virus.
May 20, 2021
0
21
A QUT researcher's identification of saliva as an early detection liquid biopsy for oral and throat cancer has been realized by the development and commercialisation of a diagnostic device by US-based biotech company Viome.
May 7, 2021
0
5
